# DESCRIPTION

## TECHNICAL FIELD

- relate to differentiating human pluripotent stem cells into hypothalamic neurons

## BACKGROUND ART

- describe hypothalamus function
- limitations of hormone replacement therapy

## SUMMARY OF INVENTION

### Technical Problem

- limitations of existing differentiation methods

### Solution to Problem

- hypothesize differentiation conditions
- optimize differentiation conditions
- use markers for differentiation steps
- add serum alternative KSR to medium
- add BMP4 signal to medium
- add Shh signal to medium
- adjust concentrations of signals
- incorporate dissociation culture
- confirm AVP neuron differentiation

## DESCRIPTION OF EMBODIMENTS

### 1. Method for Producing Cellular Structure Including Hypothalamic Tissue

- introduce hypothalamus
- describe structure of hypothalamus
- define human pluripotent stem cell
- describe pluripotency evaluation
- list examples of pluripotent stem cells
- describe ES cell establishment
- describe EG cell establishment
- define induced pluripotent stem cell (iPS cell)
- describe iPS cell preparation methods
- list iPS cell preparation techniques
- describe iPS cell selection using pluripotent stem cell markers
- describe iPS cell maintenance in vitro
- describe aggregate formation of human pluripotent stem cells
- describe culture vessel for aggregate formation
- describe medium for aggregate formation
- list additives for medium
- describe cell dissociation solution
- describe rapid aggregation methods
- describe culture conditions for aggregate formation
- describe evaluation of uniform population of human pluripotent stem cell aggregates
- describe step (1) of producing method
- define method for producing cellular structure
- describe suspension culture conditions
- specify bone morphogenetic protein signal transduction pathway activating substance
- specify substance acting on Shh signaling pathway
- describe differentiation into dorsal hypothalamic tissue
- describe differentiation into ventral hypothalamus
- specify concentration of bone morphogenetic protein signal transduction pathway activating substance
- specify concentration of substance acting on Shh signaling pathway
- describe use of Akt inhibitor
- describe use of ROCK inhibitor
- specify medium composition
- describe serum-free medium option
- describe serum alternative composition
- describe additional medium additives
- define method for producing cellular structure
- introduce growth-factor-free chemically defined medium
- describe initial orientation for differentiation
- obtain aggregates of hypothalamic precursor cells
- describe suspension culture of qualitatively uniform population
- introduce step (2) for further differentiation
- describe culture conditions for step (2)
- specify medium composition for step (2)
- describe detection of hypothalamic tissue-specific markers
- confirm progress of differentiation into dorsal hypothalamic tissue
- confirm progress of differentiation into ventral hypothalamic tissue
- introduce method for producing cellular structure including hypothalamic tissue
- describe step (3) of producing method
- motivate dissociation culture
- describe cell dissociation process
- specify culture vessel and coating
- describe high oxygen partial pressure condition
- specify culture conditions
- describe medium composition
- specify additives and supplements
- describe culture period and confirmation of differentiation
- introduce method for producing cellular structure including hypothalamic tissue and pituitary tissue
- describe step (i) of producing method
- specify culture conditions and medium composition
- describe culture period and confirmation of differentiation
- define surface ectoderm
- describe differentiation of surface ectoderm
- introduce method for producing cellular structure
- describe step (i) of method
- describe embodiment (A) of step (i)
- describe embodiment (B) of step (i)
- describe step (ii) of method
- describe culture conditions of step (ii)
- describe medium composition of step (ii)
- describe FGF2 in step (ii)
- describe culturing period of step (ii)
- describe step (iii) of method
- describe medium composition of step (iii)
- describe culturing period of step (iii)
- describe optional step (a)
- describe culture conditions of step (a)
- describe uses of cellular structure
- describe transplantation therapy
- describe drug screening and evaluation

### EXAMPLES

- apply previously reported method to human ES cells
- study effect of serum alternative on differentiation
- study effect of bone morphogenetic protein signal transduction pathway activating substance
- study effect of substance acting on Shh signaling pathway
- selectively differentiate into dorsal hypothalamus or ventral hypothalamus
- optimize dorsal hypothalamic induction condition
- detect other hypothalamic neurons
- induce differentiation into hypothalamic tissue and pituitary
- construct structure in which hypothalamus and pituitary are functionally integrated

### 2. Simultaneous Maturation of Hypothalamus and Pituitary

- induce simultaneous maturation of hypothalamus and pituitary
- analyze and verify simultaneous maturation

### 3. Conclusion

- summarize findings on differentiation inducing conditions

### 1. Appearance of Hypothalamic AVP Neuron

- verify appearance of AVP neurons from human iPS cells

### 2. Simultaneous Maturation of Hypothalamus and Pituitary

- verify maturation of pituitary
- evaluate effect of adjacency of hypothalamus and pituitary
- evaluate function of pituitary tissue
- evaluate function of structure in which hypothalamus and pituitary are integrated

## INDUSTRIAL APPLICABILITY

- application of invention

